Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist

Life Sciences

Volumn 65, Issue 16, 1999, Pages 1685-1694

  Endoh, Takashi ^a   Matsuura, Hirotoshi ^a   Tajima, Atsushi ^a   Izumimoto, Naoki ^a   Tajima, Chiko ^a   Suzuki, Tomohiko ^a   Saitoh, Akiyoshi ^a   Suzuki, Tsutomu ^b   Narita, Minoru ^c   Tseng, Leon ^c   Nagase, Hiroshi ^a  

^a TORAY INDUSTRIES INC   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Agonist; Antinociception; Opioid receptor; TRK 820

Indexed keywords

3,4 DICHLORO N METHYL N [1 PHENYL 2 (1 PYRROLIDINYL)ETHYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; ENADOLINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MORPHINAN DERIVATIVE; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZO[B]THIOPHENE 4 ACETAMIDE; NALFURAFINE; NALOXONE; NALTRINDOLE; PENTAZOCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SELECTIVITY; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SEDATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; CONSTRICTION, PATHOLOGIC; DRUG INTERACTIONS; HYPNOTICS AND SEDATIVES; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MORPHINANS; MOTOR ACTIVITY; NOCICEPTORS; PENTAZOCINE; RECEPTORS, OPIOID, KAPPA; SPIRO COMPOUNDS;

ANIMALIA;

EID: 0033543752     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00417-8     Document Type: Article

References (21)

1. W.R. Martin, C.G. Eades, J.A. Thompson, R.E. Huppler, and P.E. J. Gilbert, Pharmacol. Exp. Ther. 197 517-532(1976)
2. J.A.H. Lord, A.A. Waterfield, J. Hughes, and H.W. Kosterliz, Nature 267 495-499(1977)
3. R. Schulz, E. Faase, M. Wuster, and A. Herz, Life Sci. 24 843-850(1979)
4. H.W. Kosterlitz, S.J. Paterson, and L.E. Robson, Br.J.Pharmacol. 73 939-949 (1981)
5. K.H. Popio, D.H. Jackson, A.M. Ross, B.F. Schreiner, and P.N. Yu, Clin. Pharmacol. Ther. 23 281-287 (1978)
6. J.J. Stewart, N.W. Weisbrodt, and T.F. Burks, J. Pharmacol. Exp. Ther. 205 547-555 (1978)
7. R. Schulz, M. Wuster, and A. Herz, Naunyn Schmiedebergs Arch. Pharmacol. 208 255-260(1979b)
8. W.R. Martin, and J.W. Soloan, In Drug Addiction 1. Handbook of Experimental Pharmacology, ed. Martin, W.R. pp. 43-158. Berlin: Springer-Verlag. (1977)
9. R.A. Lahti, P.F. Von Voigtlander, and C. Barsuhn, Life Sci. 31 2257-2260(1982)
10. R.A. Lahti, M.M. Mickelson, J.M. McCall, and P.F. Von Voigtlander, Eur. J. Pharmacol. 109 281-284(1985)
11. C.R. Clark, B. Birchmore, N.A. Sharif, J.C. Hunter, R.G. Hill, and J. Hughes, Br. J. Pharmacol. 93 618-626 (1988)
12. J.C. Hunter, G.E. Leighton, K.G. Meechan, S.J. Boyle, D.C. Horwell, D.C. Rees, and J. Hughes, Br. J. Pharmacol. 101 183-189(1990)
13. H. Nagase, J. Hayakawa, K. Kawamura, K. Kawai, Y. Takezawa, H. Matsuura, T. Tajima, and T. Endoh, Chem. Pharm. Bull.46 366-369 (1998)
14. L.O. Randoll, and J.J. Selitto, Arch. Int. Pharmacodyn. Ther. 111 409-415 (1957).
15. Finney, D.J. "Statistical Methods in Biological Assays" 2nd Edition. New York: Haffner Publishing (1964).
16. G.F. Costello, B.G. Main, J.J. Barlow, J.A. Carroll, and J.S. Shaw, Eur. J. Pharmacol. 151 475-478(1988).
17. G.E. Leighton, M.A. Johnson, K.G. Meechan, G.R. Hill, and J. H. Hughes, Br. J. Pharmacol. 92 915-922(1987).
18. P.S. Portoghese, A.W. Lipkowski, and A.E. Takemori, Life Sci. 40 1287-1292 (1987)
19. P.S. Portoghese, M. Sultana, and A.E. Takemori, Eur. J. Pharmacol. 146 185-186(1988).
20. P.F. Von Voigtlander, R.A. Lahti, and J.H. Ludens, J. Pharmacol. Exp.Ther. 224 7-12(1983)
21. M.B. Tyers, Br. J. Pharmacol. 69 503-512 (1980).